Antiplatelet Medications: Old and Emerging Therapies

William M. Stone; Sailendra G. Naidu; Alyssa Chapital; Samuel R. Money

doi:10.1016/j.avsg.2009.03.008

Antiplatelet Medications: Old and Emerging Therapies

William M. Stone, Sailendra G. Naidu, Alyssa Chapital, Samuel R. Money

Diagnostic Radiology

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Antiplatelet medications have been proven to enhance outcomes in patients with cardiovascular disease. The ideal platelet inhibitor would be quick and reversible and would have universal response, an excellent safety profile, and proven benefit. Currently available antiplatelet medications have been demonstrated to have variable patient response. In light of this medication resistance, emerging therapies to inhibit platelet aggregation are under investigation. We review the currently available antiplatelet medications and the current state of these emerging therapies.

Original language	English (US)
Pages (from-to)	140-148
Number of pages	9
Journal	Annals of Vascular Surgery
Volume	24
Issue number	1
DOIs	https://doi.org/10.1016/j.avsg.2009.03.008
State	Published - Jan 2010

ASJC Scopus subject areas

Surgery
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.avsg.2009.03.008

Cite this

@article{54845187c80e42e09ae5faf89cd42ae6,

title = "Antiplatelet Medications: Old and Emerging Therapies",

abstract = "Antiplatelet medications have been proven to enhance outcomes in patients with cardiovascular disease. The ideal platelet inhibitor would be quick and reversible and would have universal response, an excellent safety profile, and proven benefit. Currently available antiplatelet medications have been demonstrated to have variable patient response. In light of this medication resistance, emerging therapies to inhibit platelet aggregation are under investigation. We review the currently available antiplatelet medications and the current state of these emerging therapies.",

author = "Stone, {William M.} and Naidu, {Sailendra G.} and Alyssa Chapital and Money, {Samuel R.}",

year = "2010",

month = jan,

doi = "10.1016/j.avsg.2009.03.008",

language = "English (US)",

volume = "24",

pages = "140--148",

journal = "Annals of Vascular Surgery",

issn = "0890-5096",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Antiplatelet Medications

T2 - Old and Emerging Therapies

AU - Stone, William M.

AU - Naidu, Sailendra G.

AU - Chapital, Alyssa

AU - Money, Samuel R.

PY - 2010/1

Y1 - 2010/1

N2 - Antiplatelet medications have been proven to enhance outcomes in patients with cardiovascular disease. The ideal platelet inhibitor would be quick and reversible and would have universal response, an excellent safety profile, and proven benefit. Currently available antiplatelet medications have been demonstrated to have variable patient response. In light of this medication resistance, emerging therapies to inhibit platelet aggregation are under investigation. We review the currently available antiplatelet medications and the current state of these emerging therapies.

AB - Antiplatelet medications have been proven to enhance outcomes in patients with cardiovascular disease. The ideal platelet inhibitor would be quick and reversible and would have universal response, an excellent safety profile, and proven benefit. Currently available antiplatelet medications have been demonstrated to have variable patient response. In light of this medication resistance, emerging therapies to inhibit platelet aggregation are under investigation. We review the currently available antiplatelet medications and the current state of these emerging therapies.

UR - http://www.scopus.com/inward/record.url?scp=72249086991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72249086991&partnerID=8YFLogxK

U2 - 10.1016/j.avsg.2009.03.008

DO - 10.1016/j.avsg.2009.03.008

M3 - Review article

C2 - 19619976

AN - SCOPUS:72249086991

SN - 0890-5096

VL - 24

SP - 140

EP - 148

JO - Annals of Vascular Surgery

JF - Annals of Vascular Surgery

IS - 1

ER -

Antiplatelet Medications: Old and Emerging Therapies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this